Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Depreciation and Depletion (2019 - 2025)

Puma Biotechnology (PBYI) has disclosed Depreciation and Depletion for 7 consecutive years, with $100000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion changed 0.0% year-over-year to $100000.0, compared with a TTM value of $400000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $400000.0, changed 0.0% over the prior year.
  • Depreciation and Depletion was $100000.0 for Q4 2025 at Puma Biotechnology, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $200000.0 in Q1 2021 and bottomed at $100000.0 in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $125000.0, with a median of $100000.0 recorded in 2021.
  • Peak annual rise in Depreciation and Depletion hit 0.0% in 2021, while the deepest fall reached 50.0% in 2021.
  • Year by year, Depreciation and Depletion stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for PBYI at $100000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.